Kymab Ltd

Introduction to Kymab Ltd

Kymab Ltd is a British biopharmaceutical company founded in 2009 with the aim of discovering and developing fully human monoclonal antibody therapeutics. The company's mission is to make a meaningful difference to patients' lives by advancing the frontiers of antibody-based medicine. What makes Kymab unique is its use of Kymouse, a transgenic mouse capable of producing human antibodies, which enables the development of more effective and less toxic treatments.

Services & products

Kymab Ltd offers a range of services related to the discovery, development, and commercialization of fully human monoclonal antibody therapeutics. The company's product pipeline includes treatments for immunological disorders, oncology, and infectious diseases. Customers can also buy Kymouse, a transgenic mouse strain for use in antibody discovery and development.

Location

Kymab Ltd is located in The Bennet Building (B930) on the Babraham Research Campus in Cambridge, England. The campus is home to over 60 companies and research organizations engaged in life sciences research and development, making it a hub for innovation in the field. The area is easily accessible by public transportation, with the closest options being the Babraham Park and Ride (1.2 miles), Great Shelford Train Station (3.5 miles), and Cambridge Train Station (5.6 miles).

Benefits

Customers should choose Kymab Ltd because of the company's unique approach to developing fully human monoclonal antibody therapeutics. By using Kymouse, Kymab is able to develop treatments that are more effective and less toxic than those produced by traditional methods. Additionally, the company is committed to advancing the frontiers of antibody-based medicine and making a meaningful difference to patients' lives.

Good to know

Customers should be aware that Kymab Ltd is primarily focused on the development of fully human monoclonal antibody therapeutics and does not offer a wide range of biochemical supplies or materials and chemicals.

Reviews

Customers have praised Kymab Ltd for its innovative approach to antibody-based medicine and its commitment to improving patients' lives. Many have noted the effectiveness of the company's treatments and the potential for Kymouse to revolutionize the field of antibody discovery and development.